Rebyota administered via colonoscopy not only showed efficacy in recurrent Clostridioides difficile infection, but also ...

A TLANTA -- A tapered and pulsed course of vancomycin was not significantly better than a standard course of the drug for ...

Data analyses from two real-world trials of Rebyota (fecal microbiota, live-jslm)efficacy and safety will be presented at IDWeek 2025, according to the details of a recent Ferring ...

Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), is a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections. It announced today ...

There is no cure for West Nile virus. Keystone Health shares how you can reduce your risk and what to do if you get it.

Phathom will showcase its growing leadership in GI through multiple engagements with the medical and scientific community, including a product theater presentation highlighting VOQUEZNA ® (vonoprazan) ...

Data published in the American Journal of Gastroenterology showed rapid and sustained relief of nighttime gastroesophageal reflux disease (GERD) ...

After years of symptoms and misdiagnoses, one patient shares how he learned he had a life-altering condition that challenges ...

This research was presented at the American College of Gastroenterology’s annual meeting (ACG 2025), alongside new long-term ...

Bile acid malabsorption was identified in about a third of patients with celiac disease and was linked to faster colonic transit, as well as prior cholecystectomy, according to research presented at ...

Earlier this month, Campbell County Health was named by Becker’s Hospital Review as one of the 463 hospitals nationwide with the lowest Clostridioides difficile, or C. diff, rates, joining Sheridan ...